Evidence map›Paper›PMID 15355746›Full record

ReviewCurrent rheumatology reports2004

Update on autoantibodies in rheumatoid arthritis.

S Louis Bridges

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Positional cloning of the Igl genes controlling rheumatoid factor production and allergic bronchitis in rats.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

S Louis BridgesDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 412 Lyons Harrison Research Building, Birmingham, AL 35294-0007, USA. lbridges@uab.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection of rheumatoid factor (RF) in the serum of patients with rheumatoid arthritis (RA) was one of the first indications of autoimmunity in RA. The role of RF in the diagnosis of RA has been well-documented, but it has suboptimal sensitivity and specificity. Although patients with RF-positive RA generally have more severe disease than those with RF-negative RA, RF is not a reliable predictor of disease severity in individual patients. Multiple other autoantibodies have been found in RA, with recent interest focused on those directed at cyclic citrullinated peptides. Panels of autoantibodies may ultimately prove useful in preclinical diagnosis and prediction of clinical course in patients with RA and other forms of arthritis, and provide insights into the pathogenesis of the disease.

Indexed as

AnimalsAntibodies, AntinuclearAntibody FormationAntibody SpecificityArthritis, RheumatoidAutoantibodiesBiomarkersCase-Control StudiesDisease Models, AnimalDisease ProgressionEnzyme-Linked Immunosorbent AssayForecastingHumansPredictive Value of TestsRheumatoid FactorRisk AssessmentAntibodies, AntinuclearAutoantibodiesBiomarkersRheumatoid Factor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.